Monitor for any activist investor activity or takeover interest, as the removal of the poison pill makes the company more vulnerable to unsolicited bids. The move suggests management sees low risk of hostile acquisition attempts currently.
Price Chart
Executive Summary
Vera Bradley terminated its shareholder rights plan (poison pill) effective April 17, 2026, by accelerating the expiration date from October 2026. The Board determined the plan was no longer necessary to protect shareholder value, and filed amended articles removing the designated Series A Preferred Stock.
Key Facts
- Vera Bradley terminated its shareholder rights plan effective April 17, 2026
- The Board determined the rights plan was no longer needed to protect shareholder value
- The company filed Articles of Amendment eliminating 60,000 shares of designated Series A Junior Participating Preferred Stock
- The rights plan was originally set to expire in October 2026 but was accelerated by six months
Financial Impact
No direct financial impact disclosed
Risk Factors
- Increased vulnerability to activist investors or hostile takeovers
- Potential perception of weak governance if no replacement defense mechanisms are implemented
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-025831 |
| Exhibit: ex-4320260417.htm | 0001628280-26-025831 |
| Exhibit: ex-3120260417.htm | 0001628280-26-025831 |
| Exhibit: ex-99120260417.htm | 0001628280-26-025831 |
| Document: 0001628280-26-025831-index-headers.html | 0001628280-26-025831 |
| Document: 0001628280-26-025831-index.html | 0001628280-26-025831 |
| Document: 0001628280-26-025831.txt | 0001628280-26-025831 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 4d ago | SC 13G | $6.07 | awaiting T+60 | — | $5.91 (−2.64%) |
Sep 30, 2026 26d ago | Court Ruling | $4.98 | awaiting T+60 | — | $5.91 (+18.67%) |
Sep 15, 2026 5w ago | 8-K | $4.09 | awaiting T+60 | — | $5.91 (+44.50%) |
Sep 15, 2026 5w ago | Press Release | $4.09 | awaiting T+60 | — | $5.91 (+44.50%) |
Jun 16, 2026 18w ago | Insider Cluster | $3.77 $3.14 | ▼ −16.71% | ▼ −19.86% | $5.91 (+56.76%) |
Jun 11, 2026 19w ago | 8-K | $3.46 $3.35 | ▼ −3.18% | ▼ −7.57% | $5.91 (+70.81%) |
Apr 24, 2026 26w ago | 8-K | $3.94 $3.81 | ▼ −3.30% | ▼ −8.38% | $5.91 (+50.00%) |
Apr 17, 2026 27w ago | 8-K | $4.22 $4.01 | ▼ −4.98% | ▼ −11.75% | $5.91 (+40.05%) |
Apr 17, 2026 27w ago | Press Release | $4.22 $4.01 | ▼ −4.98% | ▼ −11.75% | $5.91 (+40.05%) |
Mar 12, 2026 32w ago | 8-K | $3.38 $3.08 | ▼ −8.88% | ▼ −19.57% | $5.91 (+74.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers